$145.27 general Payment -- AstraZeneca to Dr. Heather Mitchell

Payment Details

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

AstraZeneca made a $145.27 general payment to Heather Mitchell, a Nephrology specialist in Detroit, MI. The payment was associated with Rybelsus. A payment of $145.27 was made to Dr. Heather Mitchell, a Nephrology specialist in Detroit, MI. The payment was for 'Compensation for services other than consulting' related to the drug Rybelsus. This payment occurred on November 13, 2024, from AstraZeneca.

Patient Guidance: What This Payment Means for You

This payment to your doctor is for services rendered and is publicly reported. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

For Nephrology specialists, payments for services other than consulting are common, and this amount is within a typical range for such services.

Regulatory Context: Sunshine Act Requirements

This payment is reported under the Physician Payments Sunshine Act, requiring disclosure of payments made by manufacturers to physicians.

Related Topics

This payment is related to the following healthcare transparency topics:

• nephrology
• astrazeneca
• rybelsus
• physician-payment
• cms-open-payments
• compensation-for-services

Understanding general Payments

general payments are one of several categories of financial transfers from pharmaceutical and medical device companies to physicians that must be reported under the Sunshine Act. Understanding the type and context of a payment is important for evaluating its significance. Not all payments are equal -- a research grant has very different implications than a promotional speaking fee.

Frequently Asked Questions About This Payment

What was this $145.27 payment for?

This was a general payment of $145.27 from AstraZeneca to Heather Mitchell, categorized as "Compensation for services other than consulting". It was associated with Rybelsus. The payment was reported under the Sunshine Act (CMS Open Payments).

Does Heather Mitchell accept pharmaceutical money?

Yes, Heather Mitchell received this $145.27 payment from AstraZeneca. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Heather Mitchell's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this general payment?

A general payment of $145.27 should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Nephrology?

To compare this payment against Nephrology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Nephrology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Heather Mitchell's relationship with AstraZeneca?

The payment amount is relatively small ($145.27). This $145.27 general payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Nephrology?

The payment type is 'general', indicating it's not tied to specific research or consulting.

What should patients do after learning about this payment?

This payment to your doctor is for services rendered and is publicly reported.

What else should I know about this general payment?

The payment nature specifies 'services other than consulting', suggesting a service provided by the physician.

Related Reports

• View Dr. Heather Mitchell's full payment report
• AstraZeneca full spending report
• Browse all Nephrology payments
• Browse all payments in Michigan
• Search for other payments